NDT Advance Access originally published online on April 3, 2007
Nephrology Dialysis Transplantation 2007 22(6):1512-1517; doi:10.1093/ndt/gfm167
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
For patients taking herbal therapy—lessons from aristolochic acid nephropathy
Nephrology, Dialysis and Renal Transplantation, Erasme Hospital, Université Libre de Bruxelles, 1070 Brussels, Belgium
Correspondence and offprint requests to: Joëlle L. Nortier, MD, PhD, Nephrology, Dialysis and Renal Transplantation, Erasme Hospital, Université Libre de Bruxelles, Route de Lennik, 808, 1070 Brussels, Belgium. Email: jnortier@ulb.ac.be
Keywords: Aristolochia; complementary and alternative medicine; herbal remedies; toxic nephropathy
| The first 150 words of the full text of this article appear below. |
 |
Introduction |
|---|
Herbal medicines are but one component of complementary and alternative medicine (CAM), which includes acupuncture, chiropractic manipulation, meditation, reflexology, homeopathy, folk medicine and other approaches [1]. The term ‘CAM’ has been defined by Eisenberg and colleagues in the nineties as ‘those interventions neither taught widely at US medical schools nor generally available in US hospitals’ [2]. The increasing popularity of these therapies is attested by US national surveys showing an increase of 25% in the overall prevalence of use between 1990 and 1997. The Centers for Disease Control and Prevention reported that 29% of the adults in the US used CAM in 1999, with 10% ingesting herbal medicines [1]. In 2001, 17.8 billion USD were spent on dietary supplements, and 4.2 billion USD of this were for herbs and other botanical remedies [3]. Herbal medicine is also a big business in Europe.
|
Multicultural aspects of Aristolochia species |
|---|
|
Historical discovery of aristolochic acid nephropathy |
|---|
|
The wide clinical spectrum of aristolochic acid nephropathy |
|---|
|
AAN complicated by urothelial carcinoma |
|---|
|
Tubulotoxicity and carcinogenicity of Aristolochia sp. |
|---|
|
Experimental AAN |
|---|
|
Conclusion |
|---|
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C.-H. Kang, C.-H. Chen, and P.-H. Chiang Primary Urothelial Carcinoma of the Upper Urinary Tract in Dialysis Patients with 5-year Follow-up Jpn. J. Clin. Oncol., November 22, 2009; (2009) hyp143v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Hu, M. Noor, Y. F. Wong, P. J. Hylands, M. S. J. Simmonds, Q. Xu, D. Jiang, B. M. Hendry, and Q. Xu In vitro anti-fibrotic activities of herbal compounds and herbs Nephrol. Dial. Transplant., October 1, 2009; 24(10): 3033 - 3041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-P. Grunfeld Kidney Diseases: Environmental and Genetic Factors Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 654 - 657. [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-L. Lin, H.-H. Chen, and T.-W. Chen Asymptomatic renal failure in a patient with bipolar disease without lithium therapy NDT Plus, February 1, 2008; 1(1): 45 - 48. [Full Text] [PDF]
|
|